[Skip to Content]
[Skip to Content Landing]

Uvular Lesion in a 62-Year-Old Man

Educational Objective
Based on this clinical scenario and the accompanying image, understand how to arrive at a correct diagnosis.
1 Credit CME

A 62-year-old healthy man with no recent travel history or sick contacts presented with 2 weeks of midline sore throat without systemic signs, such as fever, myalgia, or rash. A physical examination, including flexible laryngoscopy, revealed cobbling, adherent, thick yellow mucus and ulceration of the uvula (Figure 1A).

Empirical treatment with augmentin and nystatin oral suspension for possible bacterial or fungal pharyngitis was unsuccessful, with symptoms worsening during the subsequent 2 weeks. Results of laboratory testing for group A Streptococcus, COVID-19, and mononucleosis were negative. A tissue biopsy was performed, and results of pathology revealed epithelial hyperplasia with suppurative granulomatous inflammation without evidence of dysplasia or malignancy. There was no evidence of fungal or acid-fast organisms. Tissue culture revealed only normal respiratory flora. Additional treatment with fluconazole, augmentin, doxycycline, omeprazole, prednisone, and bactrim failed to improve symptoms.

Please finish quiz first before checking answer.

You answered correctly!

Read the answer below and download your certificate.

You answered incorrectly.

Read the discussion below and retake the quiz.

A 62-year-old healthy man with no recent travel history or sick contacts presented with 2 weeks of midline sore throat without systemic signs, such as fever, myalgia, or rash. A physical examination, including flexible laryngoscopy, revealed cobbling, adherent, thick yellow mucus and ulceration of the uvula (Figure 1A).

Empirical treatment with augmentin and nystatin oral suspension for possible bacterial or fungal pharyngitis was unsuccessful, with symptoms worsening during the subsequent 2 weeks. Results of laboratory testing for group A Streptococcus, COVID-19, and mononucleosis were negative. A tissue biopsy was performed, and results of pathology revealed epithelial hyperplasia with suppurative granulomatous inflammation without evidence of dysplasia or malignancy. There was no evidence of fungal or acid-fast organisms. Tissue culture revealed only normal respiratory flora. Additional treatment with fluconazole, augmentin, doxycycline, omeprazole, prednisone, and bactrim failed to improve symptoms.

Survey Complete!

Sign in to take quiz and track your certificates

Buy This Activity

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Article Information

Corresponding Author: Nsangou Ghogomu, MD, MA, Colorado Permanente Medical Group, 2045 N Franklin St, Denver, CO 80205 (nsangou.ghogomu@kp.org).

Published Online: August 17, 2023. doi:10.1001/jamaoto.2023.2223

Conflict of Interest Disclosures: None reported.

Additional Contributions: We thank the patient for granting permission to publish this information. We also wish to acknowledge the contributions of Marcia Eustaquio, MD (Head & Neck Surgery, Colorado Permanente Medical Group); Daniel Mogyoros, MD (Infectious Diseases, Colorado Permanente Medical Group); Martin Potash, MD (Surgical Pathology, AP/CP Colorado Pathology Consultants); and the University of Washington Medicine Molecular Microbiology Laboratory, Seattle, Washington. These contributors were not compensated beyond their regular salaries.

References
1.
Herwaldt  BL .  Leishmaniasis.   Lancet. 1999;354(9185):1191-1199. doi:10.1016/S0140-6736(98)10178-2 PubMedGoogle ScholarCrossref
2.
Aronson  N , Herwaldt  BL , Libman  M ,  et al.  Diagnosis and treatment of leishmaniasis: clinical practice guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH).   Clin Infect Dis. 2016;63(12):1539-1557. doi:10.1093/cid/ciw742 PubMedGoogle ScholarCrossref
3.
Scope  A , Trau  H , Bakon  M , Yarom  N , Nasereddin  A , Schwartz  E .  Imported mucosal leishmaniasis in a traveler.   Clin Infect Dis. 2003;37(6):e83-e87. doi:10.1086/377045 PubMedGoogle ScholarCrossref
4.
Davies  CR , Reithinger  R , Campbell-Lendrum  D , Feliciangeli  D , Borges  R , Rodriguez  N .  The epidemiology and control of leishmaniasis in Andean countries.   Cad Saude Publica. 2000;16(4):925-950. doi:10.1590/S0102-311X2000000400013 PubMedGoogle ScholarCrossref
5.
Solomon  M , Sahar  N , Pavlotzky  F ,  et al.  Mucosal leishmaniasis in travelers with Leishmania braziliensis complex returning to Israel.   Emerg Infect Dis. 2019;25(4):642-648. doi:10.3201/eid2504.180239PubMedGoogle ScholarCrossref
AMA CME Accreditation Information

Credit Designation Statement: The American Medical Association designates this Journal-based CME activity activity for a maximum of 1.00  AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

  • 1.00 Medical Knowledge MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program;;
  • 1.00 Self-Assessment points in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification program;
  • 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program;
  • 1.00 Lifelong Learning points in the American Board of Pathology’s (ABPath) Continuing Certification program; and
  • 1.00 credit toward the CME [and Self-Assessment requirements] of the American Board of Surgery’s Continuous Certification program

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting MOC credit.

Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
Want full access to the AMA Ed Hub?
After you sign up for AMA Membership, make sure you sign in or create a Physician account with the AMA in order to access all learning activities on the AMA Ed Hub
Buy this activity
Close
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Education Center Collection Sign In Modal Right
Close

Name Your Search

Save Search
With a personal account, you can:
  • Access free activities and track your credits
  • Personalize content alerts
  • Customize your interests
  • Fully personalize your learning experience
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close